Cargando…
Transarterial Therapy: An Evolving Treatment Modality of Hepatocellular Carcinoma
Liver cancer is the fifth most common cancer in men, the seventh most common in women, and the third most common cause of death from cancer worldwide. Only 30-40% of liver cancer patients present early enough to undergo curative treatments such as surgery or liver transplantation. Local treatment wi...
Autores principales: | Jazieh, Khalid A., Arabi, Mohammad, Khankan, Azzam A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271007/ https://www.ncbi.nlm.nih.gov/pubmed/25434313 http://dx.doi.org/10.4103/1319-3767.145315 |
Ejemplares similares
-
Evolving therapies in the treatment of hepatocellular carcinoma
por: Spangenberg, Hans Christian, et al.
Publicado: (2008) -
Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
por: Zhong, Bin-Yan, et al.
Publicado: (2023) -
Conventional Transarterial Chemoembolization Versus Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Bzeizi, Khalid I., et al.
Publicado: (2021) -
The Current Practice of Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma
por: Shin, Sung Wook
Publicado: (2009) -
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
por: Kallini, Joseph Ralph, et al.
Publicado: (2016)